TLR8 Gene
Introduction
Tlr8 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene"> [@bsibsi2002]
<table> [@gorden2006]
<tr><th colspan="2" style="background:#f0f0f0; text-align:center; font-size:1.1em;">TLR8 Gene</th></tr> [@heil2004]
<tr><td><strong>Gene Symbol</strong></td><td>TLR8</td></tr> [@tanji2013]
<tr><td><strong>Full Name</strong></td><td>Toll-Like Receptor 8</td></tr> [@kawai2007]
<tr><td><strong>Chromosomal Location</strong></td><td>Xp22.2</td></tr> [@heneka2015]
<tr><td><strong>NCBI Gene ID</strong></td><td>[51311](https://www.ncbi.nlm.nih.gov/gene/51311)</td></tr> [@glass2010]
<tr><td><strong>OMIM</strong></td><td>300366</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000101916</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q9NYK5](https://www.uniprot.org/uniprot/Q9NYK5)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Pattern Recognition Receptor (TLR family)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Rheumatoid Arthritis, Viral Infections, Systemic Lupus Erythematosus</td></tr>
</table>
</div>
Overview
Mermaid diagram (expand to render)
TLR8 (Toll-Like Receptor 8) encodes an endosomal pattern recognition receptor that plays crucial roles in antiviral immunity and autoimmune responses. Located on the X chromosome at Xp22.2, TLR8 is primarily expressed in myeloid cells and recognizes single-stranded RNA (ssRNA) from viruses as well as synthetic antiviral compounds. Unlike TLR7, which is located on the X chromosome and escapes X-inactivation in females, TLR8 undergoes complete X-inactivation, leading to expression from only one allele in female cells. TLR8 has emerged as an important player in neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease), where it contributes to neuroinflammation through recognition of endogenous nucleic acids released from dying [neurons](/entities/neurons).
TLR8 belongs to the TLR7/8/9 subfamily of endosomal TLRs that specialize in nucleic acid recognition. These receptors are located primarily in endoplasmic reticulum-derived endosomes, where they survey for incoming pathogens. TLR8 forms functional homodimers upon ligand binding, similar to TLR7, but has distinct ligand specificity and expression patterns.
Protein Structure
Extracellular Domain
The TLR8 protein contains several distinctive structural features:
- Leucine-rich repeat (LRR) domain: Consists of 25 LRR motifs that form the ligand-binding region
- Z-loop: A unique insertion between LRR14 and LRR15 that undergoes proteolytic cleavage and is required for ligand recognition
- Ligand-binding pocket: Recognizes guanosine- and uridine-rich ssRNA sequences
- Glycosylation: Multiple N-linked glycosylation sites affect folding and trafficking
Transmembrane and Intracellular Domains
- Single transmembrane helix: Contains a sorting motif for endosomal localization
- TIR domain: Intracellular signaling domain approximately 200 amino acids
- BB loop: Critical for adaptor protein interactions
Structural Insights
Crystal structures of TLR8 have revealed:
- Dimerization mechanism: Two TLR8 monomers form a "m-shaped" dimer upon ligand binding
- Ligand recognition: Small molecules and ssRNA bind in the central dimerization interface
- Species differences: Human TLR8 has different agonist sensitivity compared to mouse TLR8
Normal Physiological Functions
Viral RNA Recognition
TLR8's primary function is detection of viral ssRNA:
Endosomal localization: TLR8 is retained in the endoplasmic reticulum and traffics to endosomes upon activation
Ligand delivery: Viral RNA is delivered to endosomes through endocytosis
Proteolytic processing: Endosomal proteases cleave TLR8, enabling ligand binding
Dimerization: Two cleaved TLR8 molecules dimerize with bound ligand
Signaling initiation: TIR domains dimerize and recruit adaptor proteinsSignaling Pathways
TLR8 activates innate immune signaling through multiple pathways:
| Pathway | Key Components | Outcome |
|---------|-----------------|---------|
| MyD88-dependent | MyD88 → IRAK4/1 → TRAF6 | [NF-κB](/entities/nf-kb), AP-1 activation |
| NF-κB pathway | TAK1 → IKK complex | Proinflammatory gene expression |
| MAPK pathway | ERK, JNK, p38 activation | Cytokine production, cell activation |
| IRF pathway | IRF7 activation | Type I interferon response |
Cellular Functions
TLR8 activation induces various immune cell responses:
- Monocyte activation: Proinflammatory cytokine production (TNF-α, IL-6, IL-12)
- Neutrophil activation: Enhanced survival and antimicrobial activity
- Dendritic cell maturation: Increased co-stimulatory molecule expression
- B cell activation: Enhanced antibody responses
- T cell modulation: Can enhance or inhibit T cell responses
Expression Pattern
Immune Cell Expression
TLR8 shows distinctive expression in immune cells:
- Monocytes/macrophages: High expression, primary responders
- Neutrophils: High expression, rapid responses
- Myeloid dendritic cells: Moderate to high expression
- Plasmacytoid dendritic cells: Low expression (TLR7 dominates)
- B cells: Low to moderate expression
Tissue Distribution
- Highest expression: Peripheral blood leukocytes, spleen
- High expression: Lung, liver
- Moderate expression: Heart, placenta
- Brain expression: Primarily [microglia](/cell-types/microglia-neuroinflammation) and infiltrating immune cells
Brain Expression
Within the central nervous system:
- Microglia: Primary TLR8-expressing cells in the brain
- Infiltrating monocytes: Contribute to neuroinflammation
- Neurons: Very low or absent expression under normal conditions
- [Astrocytes](/entities/astrocytes): Limited expression
Role in Neurodegeneration
Alzheimer's Disease
TLR8 has several connections to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:
- Endogenous ligand recognition: May detect extracellular RNA from dying neurons
- Microglial activation: TLR8 on microglia contributes to chronic neuroinflammation
- Amyloid interaction: May modulate microglial responses to [amyloid-beta](/proteins/amyloid-beta) plaques
- Autoimmune component: May recognize endogenous "self-RNA" in autoimmune contexts
- Sex differences: X-chromosome location may contribute to sex-biased disease prevalence
Parkinson's Disease
TLR8 plays a role in [Parkinson's disease](/diseases/parkinsons-disease) through:
- Nucleic acid release: Dying dopaminergic neurons release nucleic acids
- Microglial TLR8: Recognizes extracellular RNA, triggering inflammation
- [Alpha-synuclein](/proteins/alpha-synuclein) interaction: May recognize RNA bound to alpha-synuclein
- Inflammatory cascade: Contributes to chronic neuroinflammation in substantia nigra
- Sex-specific effects: X-chromosome location may explain some sex differences in PD
Rheumatoid Arthritis
- Synovial expression: TLR8 is overexpressed in rheumatoid arthritis synovium
- Joint inflammation: Contributes to inflammatory cascade in joints
- Therapeutic target: TLR8 antagonists being investigated
Systemic Lupus Erythematosus (SLE)
- Autoantibody generation: TLR8 activation may contribute to autoimmunity
- Endogenous ligand recognition: May recognize self-RNA in immune complexes
- Type I interferon: Contributes to the interferon signature in SLE
Molecular Mechanisms in Neurodegeneration
Neuroinflammation Pathways
TLR8 contributes to neuroinflammation through:
Microglial activation: Direct activation by extracellular RNA
Cytokine production: TNF-α, IL-1β, IL-6, and other proinflammatory mediators
Nitric oxide production: Induction of inducible nitric oxide synthase
[Reactive oxygen species](/entities/reactive-oxygen-species): NADPH oxidase activation
[Blood-brain barrier](/entities/blood-brain-barrier) disruption: Matrix metalloproteinase induction
Neuronal toxicity: Direct and indirect effects on neuron viabilityEndogenous Ligands
TLR8 can be activated by endogenous ligands:
- Extracellular RNA: Released from dying neurons
- RNA-containing immune complexes: From autoimmune conditions
- MicroRNA: Some studies suggest miRNA can activate TLR8
- Altered self-RNA: Modified or mislocalized cellular RNA
This endogenous activation may contribute to sterile inflammation in neurodegeneration.
Therapeutic Targeting
TLR8 Antagonists
Several TLR8 antagonists are under development:
| Compound | Mechanism | Development Stage |
|----------|-----------|-------------------|
| CU-CPT8m | Small molecule antagonist | Preclinical |
| C909 | TLR8-specific antagonist | Research |
| Imidazoquinoline derivatives | Ligand competitors | Research |
| Oligonucleotide-based | Decoy TLR8 ligands | Research |
Anti-inflammatory Approaches
- Natural compounds: Some flavonoids and terpenoids inhibit TLR8
- Broad-spectrum TLR inhibitors: Target multiple TLRs including TLR8
- downstream blockers: Target signaling molecules (TAK1, IKK)
Challenges
- Immune suppression risk: Blocking TLR8 may impair antiviral immunity
- Compartmentalization: Endosomal vs. cell surface TLR8 may differ
- Redundancy: Other TLRs may compensate if TLR8 is blocked
- Sex-specific effects: Need to consider X-inactivation in females
Genetic Variation
TLR8 Polymorphisms
Genetic variants in TLR8 affect function:
- 1-bp deletion (GT): Common variant affecting function in some populations
- Missense variants: Various amino acid changes with functional consequences
- Expression variants: Affect expression levels
These variants may influence susceptibility to infections and autoimmune diseases.
X-Chromosome Location
- X-inactivation: TLR8 undergoes complete X-inactivation
- Female mosaicism: Females express only one TLR8 allele per cell
- Sex differences: May contribute to differences in immune responses between sexes
Research Directions
Current areas of active investigation include:
Selective antagonists: Developing TLR8-specific inhibitors with better profiles
Structural studies: Understanding TLR8 activation at atomic resolution
Biomarkers: TLR8 expression as a disease biomarker
Combination therapies: TLR8 inhibitors with other immunomodulators
Sex-specific approaches: Considering X-inactivation in therapy designKey Publications
[Jurk et al., Human TLR7 or TLR8 confer responsiveness to R-848 (2002)](https://pubmed.ncbi.nlm.nih.gov/12055621/) — Original characterization of TLR8 function
[Bsibsi et al., Broad expression of TLRs in human CNS (2002)](https://pubmed.ncbi.nlm.nih.gov/12443839/) — TLR expression in brain
[Gorden et al., TLR7 and TLR8 have distinct ligand recognition (2006)](https://pubmed.ncbi.nlm.nih.gov/16625202/) — Structural basis for ligand specificity
[Heil et al., Species-specific recognition of ssRNA by TLR7 and TLR8 (2004)](https://pubmed.ncbi.nlm.nih.gov/15550249/) — Species differences
[Tanji et al., TLR8 structure reveals activation mechanism (2013)](https://pubmed.ncbi.nlm.nih.gov/23920654/) — Crystal structure of TLR8Background
The study of Tlr8 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [TLR8 Protein](/proteins/tlr8-protein)
- TLR7 Gene
- TLR9 Gene
- Toll-Like Receptor Family
- [Neuroinflammation](/mechanisms/neuroinflammation-pathway)
- [Microglia](/cell-types/microglia)
- Innate Immune Signaling
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alpha-Synuclein](/proteins/alpha-synuclein)
- [Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
External Links
- [NCBI Gene: TLR8](https://www.ncbi.nlm.nih.gov/gene/51311)
- [UniProt: TLR8](https://www.uniprot.org/uniprot/Q9NYK5)
- [Ensembl: TLR8](https://www.ensembl.org/Homo_sapiens/ENSG00000101916)
- [OMIM: TLR8](https://www.omim.org/entry/300366)
- [IUPHAR/BPS Guide to Pharmacology: TLR8](https://www.guidetopharmacology.org/target/TLR8)
References
[Jurk et al., Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12055621/)
[Bsibsi et al., Broad expression of Toll-like receptors in the human central nervous system (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12443839/)
[Gorden et al., TLR7 and TLR8 have distinct ligand recognition (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16625202/)
[Heil et al., Species-specific recognition of ssRNA by TLR7 and TLR8 (2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/15550249/)
[Tanji et al., Structure of human TLR8 (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23920654/)
[Unknown, Kawai and Akira, TLR signaling (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17253978/)
[Heneka et al., Neuroinflammation in Alzheimer's disease (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25666418/)
[Glass et al., Microglial identity and inflammatory responses in Alzheimer's disease (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20421494/)Pathway Diagram
The following diagram shows the key molecular relationships involving TLR8 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)